Association between the triglyceride glucose index and heart failure: NHANES 2007-2018

Fudan Zhang1, Xu Hou2

  • 1Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.

PubMed

Insights

The triglyceride glucose (TyG) index is linked to a higher risk of heart failure (HF) in individuals with cardiovascular disease. This index may serve as a key predictor and potential therapeutic target for HF.

Area of Science:

  • Cardiology
  • Metabolic Syndrome
  • Public Health

Background:

  • Heart failure (HF) poses a significant global health burden.
  • Understanding novel risk predictors for HF is crucial for early intervention.
  • The triglyceride glucose (TyG) index, a marker of insulin resistance, has emerged as a potential factor in cardiovascular health.

Purpose of the Study:

  • To investigate the association between the triglyceride glucose (TyG) index and the risk of heart failure (HF).
  • To explore the TyG index as a potential predictor in patients with existing cardiovascular and cerebrovascular diseases.

Main Methods:

  • Analysis of data from the National Health and Nutrition Examination Survey (NHANES) (2007-2018).
  • Inclusion of 13,825 participants, with 435 diagnosed with HF.
  • Calculation of the TyG index using ln [fasting triglyceride (mg/dL) × fasting glucose (mg/dL)/2].
  • Application of multivariate logistic regression and restricted cubic spline (RCS) analysis to assess the association and dose-response relationship.

Main Results:

  • Individuals with HF exhibited significantly higher TyG index levels compared to those without HF (8.91 ± 0.74 vs. 8.57 ± 0.66, p < 0.001).
  • A higher TyG index was associated with an increased risk of HF, with an adjusted odds ratio of 1.057 (Model 4).
  • A linear dose-response relationship was observed between the TyG index and HF risk.
  • The TyG index demonstrated predictive value for HF with an ROC curve area of 0.602 (p < 0.001).

Conclusions:

  • The triglyceride glucose (TyG) index is positively associated with an increased risk of heart failure.
  • The TyG index may serve as a valuable therapeutic target for managing and predicting HF.
  • This study highlights the clinical utility of the TyG index in cardiovascular risk assessment.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
505
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.4K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
92